German Study: Marijuana Drug Shows Promise in Treating Chronic Back Pain
A German study has found promising results for a marijuana-based drug in treating chronic back pain. The Phase III trial, led by pain specialist Matthias Karst from Hannover Medical School and published in Nature, involved 820 patients across Germany and Austria.
The experimental cannabis medication, VER-01, contains THC, the active ingredient that causes a high, but in very low levels. The low-dose formula improved pain, sleep, and physical function in patients, making it a potential safer alternative to opioids. Opioids, once commonly prescribed for long-term pain, are now discouraged due to their side effects and addiction risks.
The study, conducted by German drugmaker Vertanical, has filed for approval with European regulators and is in discussions with U.S. regulators. If approved, VER-01 could offer relief to the many chronic back pain sufferers seeking safer treatment options.
The successful trial of VER-01 brings hope for a safer, more effective treatment for chronic back pain. With approval from regulators, this marijuana-based drug could become a welcome addition to pain therapy, potentially reducing the reliance on opioids.
Read also:
- Rise in Flu Cases: Timing and Reasons Explored by Medical Experts for Flu Vaccination
- Nursing Infants: Advantages, Factors to Ponder, Guidelines, Essential Gear
- Anticipated Increase in Uninsured Residents to Pose Challenge for Local Healthcare Infrastructure
- Accusations of poor care and supposedly poor hygienic standards at LaSalle Hospital
